BTAI
BioXcel Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$0.88-0.54%
Price as of Jul 20, 2026
BTAI capital
BioXcel Therapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -0.95x
- Net debt / equity
- -0.79x
- Debt / assets
- 2.95x
- Debt / EBITDA
- -1.73x
- Net debt / EBITDA
- -1.44x
Liquidity & coverage
- Current ratio
- 0.62x
- Quick ratio
- 0.61x
- Cash ratio
- 0.31x
- Interest coverage
- -2.93x
- EBITDA / interest
- -3.37x
- Working capital
- -$21.1M
Cash & dividend
- FCF / debt
- -0.57x
- Cash flow / debt
- -0.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.